Summary
Mount Sinai doctors in New York City are using a new AI tool to better detect heart defects in unborn babies during ultrasounds. This technology, approved by the FDA, makes ultrasounds more accurate and helps identify heart problems earlier, potentially improving care for these babies.
Key Facts
- Mount Sinai is the first in New York City to use this AI tool for detecting heart defects in unborn babies.
- The AI tool is made by BrightHeart and is FDA-approved.
- Congenital heart defects are common birth issues, affecting about 1 in 500 newborns.
- One in four babies with heart defects needs surgery or other procedures in their first year.
- The AI tool improved detection rates of heart defects by more than 97%.
- It reduced the time needed to read ultrasound results by 18% and improved confidence scores by 19%.
- The study was conducted with 200 ultrasound exams from various medical centers and was funded by BrightHeart.
- Doctors suggest AI tools can make prenatal diagnosis more consistent and accessible.
